BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

822 related articles for article (PubMed ID: 20014921)

  • 41. Genomic medicine frontier in human solid tumors: prospects and challenges.
    Dienstmann R; Rodon J; Barretina J; Tabernero J
    J Clin Oncol; 2013 May; 31(15):1874-84. PubMed ID: 23589551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genome-wide mutational analyses of breast and colorectal cancers.
    Lin J; Sjöblom T
    Discov Med; 2007 Feb; 7(37):13-9. PubMed ID: 17343800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Transcriptomes for serial analysis of gene expression].
    Marti J; Piquemal D; Manchon L; Commes T
    J Soc Biol; 2002; 196(4):303-7. PubMed ID: 12645300
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma.
    Foster JM; Gatalica Z; Lilleberg S; Haynatzki G; Loggie BW
    Ann Surg Oncol; 2009 Jan; 16(1):152-8. PubMed ID: 18998063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular genetics of prostate cancer: emerging appreciation of genetic complexity.
    Barbieri CE; Demichelis F; Rubin MA
    Histopathology; 2012 Jan; 60(1):187-98. PubMed ID: 22212086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR; Liotta LA; Petricoin EF
    Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer omics: from regulatory networks to clinical outcomes.
    Tang B; Hsu PY; Huang TH; Jin VX
    Cancer Lett; 2013 Nov; 340(2):277-83. PubMed ID: 23201140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dissecting the molecular mechanisms of cancer through bioinformatics-based experimental approaches.
    Rivenbark AG; Coleman WB
    J Cell Biochem; 2007 Aug; 101(5):1074-86. PubMed ID: 17372928
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.
    Heng HH; Bremer SW; Stevens JB; Ye KJ; Liu G; Ye CJ
    J Cell Physiol; 2009 Sep; 220(3):538-47. PubMed ID: 19441078
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical cancer genomics: how soon is now?
    Taylor BS; Ladanyi M
    J Pathol; 2011 Jan; 223(2):318-26. PubMed ID: 21125684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systems medicine and metabolic modelling.
    Mardinoglu A; Nielsen J
    J Intern Med; 2012 Feb; 271(2):142-54. PubMed ID: 22142312
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical cancer genome and precision medicine.
    Roukos DH; Ku CS
    Ann Surg Oncol; 2012 Nov; 19(12):3646-50. PubMed ID: 22851046
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of genomics on the path to personalized medicine.
    Tremblay J; Hamet P
    Metabolism; 2013 Jan; 62 Suppl 1():S2-5. PubMed ID: 23021037
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer genomics: technology, discovery, and translation.
    Tran B; Dancey JE; Kamel-Reid S; McPherson JD; Bedard PL; Brown AM; Zhang T; Shaw P; Onetto N; Stein L; Hudson TJ; Neel BG; Siu LL
    J Clin Oncol; 2012 Feb; 30(6):647-60. PubMed ID: 22271477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Genomic medicine: the new way of thinking medicine present and future--Part two].
    Lamoril J; Bogard M
    Ann Biol Clin (Paris); 2014; 72(1):25-48. PubMed ID: 24492096
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reviewing the somatic genetics of melanoma: from current to future analytical approaches.
    Dutton-Regester K; Hayward NK
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):144-54. PubMed ID: 22248438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Whole cancer genome sequencing by next-generation methods.
    Ross JS; Cronin M
    Am J Clin Pathol; 2011 Oct; 136(4):527-39. PubMed ID: 21917674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Personalized therapy for breast cancer.
    De Abreu FB; Schwartz GN; Wells WA; Tsongalis GJ
    Clin Genet; 2014 Jul; 86(1):62-7. PubMed ID: 24635704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.